Covered recipient · General Payments record
REBECCA LEIGH MANGANELLO
Allopathic & Osteopathic Physicians Family Medicine Obesity Medicine
General Payments · PY2019–2024
$1,114.76
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.55 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $108.18 | 6 |
| Lilly USA, LLC | $78.06 | 5 |
| Rhythm Pharmaceuticals, Inc. | $24.53 | 1 |
| Currax Pharmaceuticals LLC | $17.33 | 1 |
| VIVUS LLC | $17.31 | 1 |
| ABBVIE INC. | $16.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.14 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103660652 | CMS |
| Currax Pharmaceuticals LLC | $17.33 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089514800 | CMS |
| Lilly USA, LLC | $15.32 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355786 | CMS |
| Lilly USA, LLC | $16.02 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355784 | CMS |
| Lilly USA, LLC | $14.73 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135352772 | CMS |
| Lilly USA, LLC | $15.76 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135361696 | CMS |
| Lilly USA, LLC | $16.23 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135382313 | CMS |
| Novo Nordisk Inc | $15.55 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097414901 | CMS |
| Novo Nordisk Inc | $15.83 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096699400 | CMS |
| Novo Nordisk Inc | $17.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096626575 | CMS |
| Novo Nordisk Inc | $21.45 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097544889 | CMS |
| Novo Nordisk Inc | $13.57 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097168684 | CMS |
| Novo Nordisk Inc | $24.78 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097591333 | CMS |
| Rhythm Pharmaceuticals, Inc. | $24.53 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141480612 | CMS |
| VIVUS LLC | $17.31 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415508 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.